Compile Data Set for Download or QSAR
maximum 50k data
Found 23 Enz. Inhib. hit(s) with all data for entry = 3437
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34017(CHEMBL104850 | phenylpropanoic acid derivative, 7)
Affinity DataIC50:  29nM EC50:  26nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM33284(BMC164883 Compound 53 | phenylpropanoic acid deriv...)
Affinity DataIC50:  185nM EC50:  140nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34025(phenylpropanoic acid derivative, 40)
Affinity DataIC50:  255nM EC50:  102nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34018(phenylpropanoic acid derivative, 28)
Affinity DataIC50:  293nM EC50:  173nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34030(phenylpropanoic acid derivative, 56 | racemic)
Affinity DataIC50:  587nM EC50:  1.80E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34034(phenylpropanoic acid derivative, 66)
Affinity DataIC50:  1.60E+3nM EC50:  480nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34027(phenylpropanoic acid derivative, 44)
Affinity DataIC50:  2.00E+3nM EC50:  3.70E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34020(phenylpropanoic acid derivative, 30 | racemic)
Affinity DataIC50:  2.20E+3nM EC50:  2.50E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34026(phenylpropanoic acid derivative, 41)
Affinity DataIC50:  2.60E+3nM EC50:  2.60E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34021(phenylpropanoic acid derivative, 31 | racemic)
Affinity DataIC50:  2.80E+3nM EC50:  1.30E+4nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34031(phenylpropanoic acid derivative, 57 | racemic)
Affinity DataIC50:  2.80E+3nM EC50:  4.00E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34028(phenylpropanoic acid derivative, 54)
Affinity DataIC50:  3.10E+3nM EC50:  2.30E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM33296(BMC164883 Compound 58 | phenylpropanoic acid deriv...)
Affinity DataIC50:  4.00E+3nM EC50:  3.90E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34033(phenylpropanoic acid derivative, 60)
Affinity DataIC50:  1.10E+4nM EC50:  3.60E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34024(phenylpropanoic acid derivative, 36)
Affinity DataIC50:  1.20E+4nM EC50:  492nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34023(phenylpropanoic acid derivative, 33)
Affinity DataIC50:  1.20E+4nM EC50:  2.00E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34029(phenylpropanoic acid derivative, 55 | racemic)
Affinity DataIC50:  2.20E+4nM EC50:  3.90E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34019(phenylpropanoic acid derivative, 29 | racemic)
Affinity DataIC50:  2.60E+4nM EC50:  4.50E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34032(phenylpropanoic acid derivative, 59)
Affinity DataIC50:  2.80E+4nM EC50:  1.20E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34035(phenylpropanoic acid derivative, 74)
Affinity DataIC50: >5.00E+4nM EC50:  9.00E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34022(phenylpropanoic acid derivative, 32 | racemic)
Affinity DataIC50:  5.30E+4nM EC50:  9.00E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34036(phenylpropanoic acid derivative, 75)
Affinity DataIC50: >1.00E+5nM EC50:  7.00E+3nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Pfizer

LigandPNGBDBM34037(phenylpropanoic acid derivative, 76)
Affinity DataIC50: >1.00E+5nM EC50: >3.00E+4nMpH: 7.4 T: 2°CAssay Description:Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed